11th Ri.MED Symposium "Restoration of Vision"
26 October 2017 - 27 October 2017
Italy
The meeting will overview the latest advances in gene therapy, neuroptotection, visual prostheses and stem cell treatments for currently incurable eye diseases. It will highlight the theoretical advances and emerging practical applications of visual information processing, optic nerve regeneration and corneal transplantation.
Special focus will be given on novel pathophysiological mechanisms and therapeutic targets for age-related macular degeneration.
The official language of the scientific talks is English.
Attendance is free of charge, but required due to space limitations.
Please, fill out the registration form at www.fondazionerimed.eu by October, 18, 2017
PROGRAM Thursday, 26 October 2017
12:00 Welcome and Introduction: Camillo Ricordi, MD, PhD - Bruno Gridelli, MD, PhD - Alessandro Padova, PhD
SESSION 1: REGENERATIVE THERAPIES FOR RESTORING VISION
14:00 “From Cone Rescue to Optogenetics” José-Alain Sahel, MD
14:30 “Neuroprotective Approaches for Retinitis Pigmentosa” Valeria Marigo, PhD
15:00 “Retinal Cell Therapy Using iPS Cells” Masayo Takahashi, MD, PhD
15:30 “Large gene delivery to the retina with AAV vectors” Alberto Auricchio, MD, PhD
16:00 Graziella Pellegrini, PhD
SESSION 2: CORNEA
17:00 Flavio Mantelli, MD, PhD
17:30 “New Strategies for the Analysis of Axonal Regeneration in the Cornea and Optic Nerve” Alain Chédotal, PhD
18:00 “The Role of MDM2/p53 in Pterygium Pathogenesis” Vishal Jhanji, PhD
PROGRAM Friday, 27 October 2017
SESSION 3: VISUAL INFORMATION PROCESSING AND VISUAL PROSTHESES
09:00 “Visual Restoration by Retinal Prostheses and Optogenetic Therapy: Preclinical Validation in Non-Human Primates” Serge Picaud, PhD
09:30 “A Fully Organic Retinal Prosthesis Restores Vision in a Rat Model of Degenerative Blindness” Fabio Benfenati, MD, PhD
10:00 “A Brain-Computer Interface for Visual Attention” Matthew A. Smith, PhD
10:30 “Targeting human retinal cell types to restore vision” Botond Roska, MD, PhD
SESSION 4: AGE-RELATED MACULAR DEGENERATION
11:30 “The Pathogenic Role of Chronic Inflammation in Age-Related Macular Degeneration” Florian Sennlaub, MD, PhD
12:00 “Cellular-Scale, Time Lapse In Vivo Imaging in the Human Eye” Michel Paques, MD, PhD
12:30 “Biomarkers and new treatments for AMD” Chiara M, Eandi, MD, PhD
SESSION 5: DEGENERATIVE EYE DISEASES
14:00 “The Crucial Impact of Lysosomes in Age-Related Macular Degeneration” Debasish Sinha, PhD
14:30 “Age-Related Macular Degeneration Biomarkers in the Aqueous Humor” GM Tosi, MD, PhD
15:00 “Novel approaches to the treatment of retinal vascular disease” Stephen Moss, PhD
Special focus will be given on novel pathophysiological mechanisms and therapeutic targets for age-related macular degeneration.
The official language of the scientific talks is English.
Attendance is free of charge, but required due to space limitations.
Please, fill out the registration form at www.fondazionerimed.eu by October, 18, 2017
PROGRAM Thursday, 26 October 2017
12:00 Welcome and Introduction: Camillo Ricordi, MD, PhD - Bruno Gridelli, MD, PhD - Alessandro Padova, PhD
SESSION 1: REGENERATIVE THERAPIES FOR RESTORING VISION
14:00 “From Cone Rescue to Optogenetics” José-Alain Sahel, MD
14:30 “Neuroprotective Approaches for Retinitis Pigmentosa” Valeria Marigo, PhD
15:00 “Retinal Cell Therapy Using iPS Cells” Masayo Takahashi, MD, PhD
15:30 “Large gene delivery to the retina with AAV vectors” Alberto Auricchio, MD, PhD
16:00 Graziella Pellegrini, PhD
SESSION 2: CORNEA
17:00 Flavio Mantelli, MD, PhD
17:30 “New Strategies for the Analysis of Axonal Regeneration in the Cornea and Optic Nerve” Alain Chédotal, PhD
18:00 “The Role of MDM2/p53 in Pterygium Pathogenesis” Vishal Jhanji, PhD
PROGRAM Friday, 27 October 2017
SESSION 3: VISUAL INFORMATION PROCESSING AND VISUAL PROSTHESES
09:00 “Visual Restoration by Retinal Prostheses and Optogenetic Therapy: Preclinical Validation in Non-Human Primates” Serge Picaud, PhD
09:30 “A Fully Organic Retinal Prosthesis Restores Vision in a Rat Model of Degenerative Blindness” Fabio Benfenati, MD, PhD
10:00 “A Brain-Computer Interface for Visual Attention” Matthew A. Smith, PhD
10:30 “Targeting human retinal cell types to restore vision” Botond Roska, MD, PhD
SESSION 4: AGE-RELATED MACULAR DEGENERATION
11:30 “The Pathogenic Role of Chronic Inflammation in Age-Related Macular Degeneration” Florian Sennlaub, MD, PhD
12:00 “Cellular-Scale, Time Lapse In Vivo Imaging in the Human Eye” Michel Paques, MD, PhD
12:30 “Biomarkers and new treatments for AMD” Chiara M, Eandi, MD, PhD
SESSION 5: DEGENERATIVE EYE DISEASES
14:00 “The Crucial Impact of Lysosomes in Age-Related Macular Degeneration” Debasish Sinha, PhD
14:30 “Age-Related Macular Degeneration Biomarkers in the Aqueous Humor” GM Tosi, MD, PhD
15:00 “Novel approaches to the treatment of retinal vascular disease” Stephen Moss, PhD
Keywords
ophthalmology, therapeutic innovations, Ri.MED, Institut de la Vision, University of Pittsburgh, age-related macular degeneration, vision restoration therapies, visual prostheses, cell treatments, optic nerve regeneration